Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Resonance Health Ltd ( (AU:RHT) ) just unveiled an announcement.
Resonance Health Ltd reported a positive net cash inflow from operations of $1.3 million for the full year, with significant progress in its clinical trial management and software-as-a-medical-device divisions. The company achieved profitability at its second TrialsWest site and secured new service contracts worth $4.5 million, reflecting growing demand for its imaging analysis services. The opening of a third clinical trial site and the development of a new ‘bridge’ technology to improve customer integration are expected to support future growth.
More about Resonance Health Ltd
Resonance Health Ltd is a company operating in the healthcare industry, specializing in clinical trial management, software-as-a-medical-device image analysis services, and clinical trial site services. The company focuses on providing services to global pharmaceutical companies and has been expanding its operations with new clinical trial sites and service contracts.
Average Trading Volume: 242,561
Technical Sentiment Signal: Sell
Current Market Cap: A$18.38M
See more insights into RHT stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money